Clough Capital Partners L P Apellis Pharmaceuticals, Inc. Transaction History

Clough Capital Partners L P

$924 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$76.68 - $93.31 $4.28 Million - $5.21 Million	55,800 Added 200.15%	83,679 $7.62 Million
Q1 2023 May 15, 2023	SELL	$46.59 - $66.96 $34,010 - $48,880	-730 Reduced 2.55%	27,879 $1.84 Million
Q4 2022 Feb 14, 2023	SELL	$43.24 - $61.04 $605,360 - $854,560	-14,000 Reduced 32.86%	28,609 $1.48 Million
Q3 2022 Nov 14, 2022	SELL	$44.76 - $69.66 $4.47 Million - $6.95 Million	-99,800 Reduced 70.08%	42,609 $2.91 Million
Q1 2022 May 16, 2022	BUY	$35.46 - $54.12 $378,003 - $576,919	10,660 Added 8.09%	142,409 $7.24 Million
Q4 2021 Feb 14, 2022	SELL	$30.74 - $49.16 $184,440 - $294,960	-6,000 Reduced 4.36%	131,749 $6.23 Million
Q2 2021 Aug 16, 2021	SELL	$40.9 - $64.9 $14.4 Million - $22.8 Million	-351,400 Reduced 71.84%	137,749 $8.71 Million
Q1 2021 May 17, 2021	BUY	$40.8 - $57.39 $10.5 Million - $14.7 Million	256,700 Added 110.43%	489,149 $21 Million
Q4 2020 Feb 16, 2021	SELL	$30.79 - $57.2 $5.34 Million - $9.92 Million	-173,385 Reduced 42.72%	232,449 $13.3 Million
Q1 2020 May 15, 2020	SELL	$17.91 - $44.33 $2.02 Million - $5.01 Million	-113,000 Reduced 21.78%	405,834 $10.9 Million
Q3 2019 Nov 14, 2019	SELL	$24.09 - $32.18 $1.77 Million - $2.36 Million	-73,300 Reduced 12.38%	518,834 $12.5 Million
Q2 2019 Aug 14, 2019	BUY	$18.0 - $25.34 $43,200 - $60,816	2,400 Added 0.41%	592,134 $15 Million
Q1 2019 May 15, 2019	BUY	$12.81 - $19.82 $345,870 - $535,140	27,000 Added 4.8%	589,734 $11.5 Million
Q4 2018 Feb 14, 2019	SELL	$11.47 - $18.71 $302,601 - $493,607	-26,382 Reduced 4.48%	562,734 $7.42 Million
Q3 2018 Nov 14, 2018	BUY	$16.57 - $21.03 $190,555 - $241,845	11,500 Added 1.99%	589,116 $10.5 Million
Q2 2018 Aug 14, 2018	SELL	$19.63 - $30.0 $863,720 - $1.32 Million	-44,000 Reduced 7.08%	577,616 $12.7 Million
Q1 2018 May 15, 2018	SELL	$14.01 - $26.02 $4.14 Million - $7.69 Million	-295,500 Reduced 32.22%	621,616 $13.7 Million
Q4 2017 Feb 14, 2018	BUY	$12.71 - $21.7 $11.7 Million - $19.9 Million	917,116	917,116 $19.7 Million

Others Institutions Holding APLS

# of Institutions

308

Shares Held

115M

Call Options Held

3.85M

Put Options Held

1.09M

Wellington Management Group LLP Boston, MA

15.6M
Shares

$516 Million
0.08% of portfolio
Eco R1 Capital, LLC San Francisco, CA

11.9M
Shares

$394 Million
14.88% of portfolio
Avoro Capital Advisors LLC New York, NY

11.1M
Shares

$368 Million
4.82% of portfolio
Vanguard Group Inc Valley Forge, PA

9.82M
Shares

$325 Million
0.01% of portfolio
Black Rock Inc. New York, NY

5.8M
Shares

$192 Million
0.01% of portfolio

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.64B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clough Capital Partners L P, based on Form 13F filings with the SEC.

News

Stay updated on Clough Capital Partners L P with notifications on news.

Account